Health ❯ Healthcare ❯ Medical Research ❯ Cancer Research

Colorectal Cancer

TROP2 Pinpoints and Permits Targeted Attack on Metastasis‑Driving Colorectal Cells

Preclinical results show approved TROP2-directed antibody–drug conjugates kill therapy-resistant, stem-like colorectal cells, leading to a Phase 2/3 trial.

4 ARTICLES

last mo.

California Study Links Birth and Parental Factors to Early‑Onset Colorectal Cancer Risk

3 ARTICLES

9mo ago

Study Identifies Early Epigenetic 'Big Bang' of Immune Escape in Bowel Cancer

4 ARTICLES

10mo ago

Engineered Salmonella Triggers Tumor Immune Hubs, Slows Colorectal Cancer in Mice

16 ARTICLES

11mo ago

Low-Dose Aspirin Halves Recurrence in PI3K-Altered Colorectal Cancer, NEJM Trial Finds

3 ARTICLES

this yr.

KRAS-Targeted Vaccine Shows Robust Immune Response, Longer-Than-Expected Survival in Pancreatic and Colorectal Cancer Trial

3 ARTICLES

last yr.

IGTP Unveils Scalable 3D Spheroid Model for Colorectal Cancer

3 ARTICLES

last yr.

Coexisting Adenomas and Serrated Polyps Linked to Fivefold Rise in Bowel Precancer Risk

3 ARTICLES

last yr.

Chronic Gum Disease Found in Almost 70% of Colorectal Cancer Patients

3 ARTICLES

last yr.

Ohio State Researchers Develop PANDA for Noninvasive Colorectal Cancer Diagnosis and Monitoring

19 ARTICLES

last yr.

Bacterial Toxin Linked to Surge in Early-Onset Colorectal Cancer